That was the major support last time around and will become the next resistance.
Federal Program for Distressed Homeowners Is Extended
By JACKIE CALMES
Published: May 30, 2013
See article under Yahoo.
This is great news for FNMA and FMCC.
"Fannie's preferred Series E shares, with a face value of $50, plunged 32% to close at $10.26, following a 24.5% decline on Wednesday. The shares trade under the symbol FNMFM." the commons were down
What does this means you ask? We if only that could mean one thing but with preferred also down 2 days in a row this tells me last 2 days were just manipulation to steal your shares and as greedy as the criminal hedges are they decided to also steal the preferred and scare the weak hands.
Hold tight to your shares as we'll be going up; Remember this is the biggest company in the world and government has no other alternatives.
Sentiment: Strong Buy
Criminals at work; Someone needs to report them to SEC.
see latest Yahoo news on ZNGA.
Sentiment: Strong Buy
Also note that as if a RS price of 55 cents was not enough they are ALSO DILUTING the number of shares to the tune of 2.27 billion shares post RS which translates to 27.7 billion shares.
This stock is not even worth 55 cents but much less when you include the dilution.
Sentiment: Strong Sell
That was then this is now. This morning they clearly said
"May 20 (Reuters) - Greece's biggest lender National Bank said on Monday it would sell 2.27 billion new shares at a price of 4.29 euros ($5.50) each, as part of its recapitalisation plan."
Confusing the issue by hashing up something from months ago does help. Read above PR from this morning one more time. It is short and ver clear and to the point and without any ifs or buts.
Bank thinks their shares is worth 55 cents a share that is why they are selling billions of ADDED shares at 1-10 RS price of 5.50 which is exactly 55 cents today and before the RS.
Short NBG as it has way more down to go.
I believe if there are no news soon this will go below last week's 0.80.
Once the real number of injuries and deaths caused by this useless over-rated toy is known they would need a reverse split.....
Sentiment: Strong Sell
1-nil you say??????you'd be surprised if you could look up the number of cases that are quietly settled (with non-disclosure clauses) before they even get to the court??? Unfortunately there is no way for anyone right now to prove this but those in the medical field nationwide have known about the ones in their individual institutions for the longest time.
Sentiment: Strong Sell
Despite company admitting today that they have a problem, and despite such a lofty PE, the stock was down a little over 1% on a volume of only about 65% over daily average. The stock was down over 3.5% at one time today but recovered most losses as market recovered. The initial bigger drop along with low volume and subsequent recovery makes it abundantly clear that not only the news had not spread wide yet but that eveb those investors that had heard the bad news needed more time to evaluate the impact of the latest problem with these robotics which appeared on top of all the other problems but seems more major.
Expect a major bloodbath on Monday or smaller daily ones for the whole of next week. Remember these are medical devices that deal with patient's lives. Just look at what happened to Affymax after reporting only 3 deaths among more than 25000 treated.
Sentiment: Strong Sell
With the latest 10 Q the risk/reward ratio got smashed again as they raised issues with their funds again and possibility of BK despite the latest Takeda agreement. I had to read their latest 10 Q over and over in order to realize that this management (CEO, CFO, etc) are not the only incompetent folks there but also their board, who supposed to watch over things, does not seem to have a clue about how to control the costs and while the company does not have much Omontys related expenses they seem to continue to be in real trouble.
With such incompetent and stupid people running this company to the ground who says that one morning they may not opt for BK? They pulled the plug on a billion dollar drug over 0.02% fatality rate didn't they?
With such major risks to me any entry point without a bounce off the 0.80 low of earlier this week is pure gamble and a not so smart one. It has to test 0.80 before I would consider getting back in.
Thanks but this was a heck of a roller coaster for a 30% profit though it is such a relief to be out and not have to deal with such a rookie lunatic management.
This management sounds pretty nasty and crazy. Risk/reward is become pretty lopsided provided how stupid the management is.
I am completely out but may get back in when risk/reward becomes more attractive at around 0.80 or lower.
Good luck to all.
There is absolutely NOTHING NEW in the latest 10Q just a regurgitation of the same garbage this incompetent man agent who seem to also have ulterior motives and always want to crush the pps.
Just look at the timing of the release of this latest 10Q !!!
The stock more than doubles over a 3 day period but to this stupid and corrupt management the advance is intolerable and has to be STOPPED and hence the timing of release AH of what they've kept up their sleeve which clearly contains nothing new.
Funny thing is that this was a predictable move by this GANG. From day one when they VOLUNTARILY recalled Omontys over a meager and not so uncommon 0.02% ( or 3 in over 25000 usage) it is been obvious, and many retail investors, doctors, and analysts have said so, that something fishy is going on with this management.
If you notice they keep quite while the stock is tumbling for lack of any pr but whenever it seems to finally find its footing and begins advancing there comes a pr designed to cut the legs from under this stock.
Could it be that they are not satisfied how many shares on the cheap their master, Takeda, and their other bosses have accumulated yet?
Takeda and their puppet Affymax know very well that in the light of baseless reason for which they pulled O as well as billions in potential royalties in future years that NO US BK JUDGE will even consider a bk application so they are trying to buy the company on the cheap by first accumulating all the shares they can before announcing the buy out. However to their disappointment the institutional investors that hold over 80% of the shares have refused to sell hence such desperate management moves such as timing of this latest pr.
Lets call their bluff and hold on to our shares and if we can afford it lets add on any dips.
Sentiment: Strong Buy
AFFY was trading between $3.50-4.00 for weeks before the possibility of bk suddenly knocked it down. Now that it is plenty obvious that no bk is in the cards it should and will return back to its BASE of $3.50-4.00 shortly even without any further news. Period.
Sentiment: Strong Buy
You don't get that kind of move based on a single SA article or retail buyers when over 80% is owned by institutions. Something is up and it is BIG. I think the run will continue until around $3.50, where it was for a long while before the bk scare crushed it, and then will wait for the news.
Sentiment: Strong Buy
Your numbers are way off because once O is back in the market it will beat Amgen's numbers within a couple of years.
Sentiment: Strong Buy
Gosh we've been saying this for awhile now but it keeps going down but despite the disappointment, as I had said, I plan to add shares if this drops a bit further as I just can't see how Affymax will be allowed to file bk by any bk judge until the status of Omontys is known.